TABLE 4.
Hazard ratio | 95% confidence interval (lower, upper) | P value | |
---|---|---|---|
Age (per decade) | 1.15 | (1.11, 1.20) | <.001 |
Year of diagnosis (ref = 2006) | 0.98 | (0.97, 0.99) | .005 |
Female sex | 0.79 | (0.75, 0.84) | <.001 |
Race (ref = white) | |||
Black | 0.99 | (0.89, 1.10) | .84 |
Other | 0.85 | (0.72, 1.01) | .06 |
Charlson Comorbidity Score (ref = 0) | |||
1 | 1.15 | (1.08, 1.22) | <.001 |
2+ | 1.26 | (1.16, 1.37) | <.001 |
Education (per quartile) | 1.00 | (0.96, 1.04) | .97 |
Income (per quartile) | 0.97 | (0.93, 1.00) | .052 |
Insurance status (ref = private) | |||
Medicare/Medicaid | 1.20 | (1.12, 1.29) | <.001 |
Other government | 1.09 | (0.81, 1.46) | .58 |
Unknown | 1.08 | (0.81, 1.44) | .61 |
Uninsured | 1.36 | (1.12, 1.64) | .002 |
AJCC pathologic T stage | 1.24 | (1.19, 1.28) | <.001 |
AJCC pathologic N2 (vs Nl) | 1.40 | (1.32, 1.50) | <.001 |
Pneumonectomy (vs lobectomy) | 1.06 | (0.98, 1.16) | .14 |
Length of stay (per day) | 1.02 | (1.02, 1.03) | <.001 |
Readmission | 1.25 | (1.11, 1.41) | <.001 |
Facility type (ref = community) | |||
Comprehensive community program | 0.84 | (0.76, 0.93) | .001 |
Research/academic program | 0.76 | (0.68, 0.84) | <.001 |
Guideline-concordant adjuvant therapy | 0.66 | (0.62, 0.70) | <.001 |
AJCC, American Joint Committee on Cancer.